Hydrogel formulations for orthotopic treatment of myocardial infarction
Q Luo, Z Li, B Liu, J Ding - Expert Opinion on Drug Delivery, 2024 - Taylor & Francis
Introduction Myocardial infarction (MI) causes extensive structural and functional damage to
the cardiac tissue due to the significant loss of cardiomyocytes. Early reperfusion is the …
the cardiac tissue due to the significant loss of cardiomyocytes. Early reperfusion is the …
Biomaterials based cardiac patches for the treatment of myocardial infarction
Myocardial infarction (MI) is one of the common cardiovascular diseases that occurs with a
blockage in one or more of the coronary arteries to lead to the damage of the myocardium …
blockage in one or more of the coronary arteries to lead to the damage of the myocardium …
Myocardial‐infarction‐responsive smart hydrogels targeting matrix metalloproteinase for on‐demand growth factor delivery
C Fan, J Shi, Y Zhuang, L Zhang, L Huang… - Advanced …, 2019 - Wiley Online Library
Although in situ restoration of blood supply to the infarction region and attenuating pre‐
existing extracellular matrix degradation remain potential therapeutic approaches for …
existing extracellular matrix degradation remain potential therapeutic approaches for …
Biologics and their delivery systems: Trends in myocardial infarction
Cardiovascular disease is the leading cause of death around the world, in which myocardial
infarction (MI) is a precipitating event. However, current therapies do not adequately address …
infarction (MI) is a precipitating event. However, current therapies do not adequately address …
Toward regeneration of the heart: bioengineering strategies for immunomodulation
A Ferrini, MM Stevens, S Sattler… - Frontiers in …, 2019 - frontiersin.org
Myocardial Infarction (MI) is the most common cardiovascular disease. An average-sized MI
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …
causes the loss of up to 1 billion cardiomyocytes and the adult heart lacks the capacity to …
Sustained release systems for delivery of therapeutic peptide/protein
Peptide/protein therapeutics have been significantly applied in the clinical treatment of
various diseases such as cancer, diabetes, etc. owing to their high biocompatibility …
various diseases such as cancer, diabetes, etc. owing to their high biocompatibility …
Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following …
Following myocardial infarction (MI), the destruction of vasculature in the infarcted heart
muscle and progression of cardiac fibrosis lead to cardiac function deterioration …
muscle and progression of cardiac fibrosis lead to cardiac function deterioration …
Recent approaches for angiogenesis in search of successful tissue engineering and regeneration
Angiogenesis plays a central role in human physiology from reproduction and fetal
development to wound healing and tissue repair/regeneration. Clinically relevant therapies …
development to wound healing and tissue repair/regeneration. Clinically relevant therapies …
Essential role of nonessential amino acid glutamine in atherosclerotic cardiovascular disease
J Chen, S Zhang, J Wu, S Wu, G Xu, D Wei - DNA and Cell Biology, 2020 - liebertpub.com
Atherosclerosis is a major disease that seriously harms human health and is known as the
“number one killer” in developed countries and the leading cause of death worldwide …
“number one killer” in developed countries and the leading cause of death worldwide …
[HTML][HTML] Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions
Heart muscle injury and an elevated troponin level signify myocardial infarction (MI), which
may result in defective and uncoordinated segments, reduced cardiac output, and ultimately …
may result in defective and uncoordinated segments, reduced cardiac output, and ultimately …